COCH

What one share of Envoy Medical holds

Orthopedic, Prosthetic and Surgical Appliances and Supplies

We are a hearing health company focused on providing innovative medical technologies across the hearing loss spectrum. Our technologies are designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they desire.

Envoy Medical’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.

Per-share figures
Sales$0.00
Profit−$0.51
Capex (buildings and equipment)$0.00
Free cash flow−$0.39
Cash and investments$0.25
Book value$0.04

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2022$0.02−$1.57$0.02−$0.89—−$3.58
2023$0.03−$2.54$0.01−$1.40—−$0.09
2024$0.01−$1.49$0.05−$1.01—−$0.88
2025$0.01−$1.23$0.01−$0.79—−$0.16

Common questions about Envoy Medical

How much does one share of Envoy Medical earn?

Over the last 12 months, Envoy Medical lost $0.51 for each share on $0.00 of sales.

Does Envoy Medical pay a dividend?

Envoy Medical didn’t pay a dividend over the last 12 months, according to its SEC filings.

What is Envoy Medical’s book value per share?

Envoy Medical’s book value is $0.04 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.

How much cash and debt does each share of Envoy Medical have?

Each share of Envoy Medical has $0.25 of cash and investments, as of June 30, 2026.

What is Envoy Medical’s free cash flow per share?

−$0.39 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.

Has Envoy Medical bought back shares?

Envoy Medical’s share count rose about 130% from 2022 to 2025. That dilution means each share owns a smaller slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.